Patent · US Active

Subunit vaccine for treatment or prevention of a respiratory tract infection

US12162907B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignee

Valneva SE · FR

Inventors

Fabien Perugi · Nantes, FR
Klaus Schwamborn · Nantes, FR
Wolfgang Schüler · Wien, AT
Urban Lundberg · Wien, AT
Andreas Meinke · Pressbaum, AT

Key dates

Filing date	May 19, 2020
Grant date	Dec 10, 2024
Priority date	—
Expiry date	Aug 9, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18334
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to modified metapneumovirus (hMPV) F proteins, stabilized in the pre-fusion conformation. It also relates to immunogenic compositions (vaccines) comprising these proteins for preventing and/or treating human subjects against respiratory tract infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.